IN2012DN02705A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02705A
IN2012DN02705A IN2705DEN2012A IN2012DN02705A IN 2012DN02705 A IN2012DN02705 A IN 2012DN02705A IN 2705DEN2012 A IN2705DEN2012 A IN 2705DEN2012A IN 2012DN02705 A IN2012DN02705 A IN 2012DN02705A
Authority
IN
India
Application number
Inventor
Lingwood Clifford
Original Assignee
Hospital For Sick Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital For Sick Children filed Critical Hospital For Sick Children
Publication of IN2012DN02705A publication Critical patent/IN2012DN02705A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN2705DEN2012 2009-08-28 2012-03-28 IN2012DN02705A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23791009P 2009-08-28 2009-08-28
PCT/CA2010/001360 WO2011022843A1 (en) 2009-08-28 2010-08-27 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins

Publications (1)

Publication Number Publication Date
IN2012DN02705A true IN2012DN02705A (en) 2015-09-04

Family

ID=43627127

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2705DEN2012 IN2012DN02705A (en) 2009-08-28 2012-03-28

Country Status (8)

Country Link
US (2) US20120201853A1 (en)
EP (1) EP2470192B1 (en)
JP (1) JP2013503112A (en)
AU (1) AU2010286248A1 (en)
CA (1) CA2772441C (en)
ES (1) ES2622840T3 (en)
IN (1) IN2012DN02705A (en)
WO (1) WO2011022843A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691306A (en) * 1993-08-26 1997-11-25 National Research Council Of Canada Methods of detection and treatment of protein trafficking disorders and increasing secretory protein production
WO2002009642A2 (en) * 2000-07-28 2002-02-07 University Of Maryland, Baltimore Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel
EP1496116B1 (en) * 2002-02-04 2010-06-16 Yoshida, Hideo Anticancer agents using vero toxin variants
US20090239807A1 (en) * 2004-05-24 2009-09-24 Mia Horowitz Methods and kits for diagnosing and/or assessing severity and treating gaucher disease
CA2712593A1 (en) * 2008-02-01 2009-08-13 The Scripps Research Institute Methods for treating a condition characterized by dysfunction in protein homeostasis

Also Published As

Publication number Publication date
CA2772441C (en) 2020-04-14
US9901612B2 (en) 2018-02-27
CA2772441A1 (en) 2011-03-03
EP2470192B1 (en) 2017-04-05
WO2011022843A1 (en) 2011-03-03
EP2470192A1 (en) 2012-07-04
AU2010286248A1 (en) 2012-04-12
US20120201853A1 (en) 2012-08-09
EP2470192A4 (en) 2013-10-16
ES2622840T3 (en) 2017-07-07
US20140371130A1 (en) 2014-12-18
JP2013503112A (en) 2013-01-31

Similar Documents

Publication Publication Date Title
BR112012003062A2 (en)
BR112012000607A2 (en)
BRPI0925311A2 (en)
BRPI0924307A2 (en)
BR122021004633A2 (en)
BR112012003080A2 (en)
BR122017024704A2 (en)
BR112012000665A2 (en)
BR112012007656A2 (en)
BR112012001263A2 (en)
BR112012002627A2 (en)
BR112012000159A2 (en)
BRPI1004942A2 (en)
BRPI0924534A2 (en)
BR112012007654A2 (en)
BR112012005951A2 (en)
BR112012000255A2 (en)
BR112012000156A2 (en)
BRPI0924617A2 (en)
BR112012007671A2 (en)
BRPI0925022A2 (en)
BR112012000689A2 (en)
BR112012003654A2 (en)
BRPI0925016A2 (en)
BRPI0924020A2 (en)